Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 3/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ACLY | P53396 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | JUN | P05412 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21944872 | 0.88 | ERN1 (0.50) | ERN1KCNH2CNR1CNR2SMN1; SMN2 | |
| SCHEMBL154838 | 0.86 | CNR2 (0.50) | ERN1KCNH2CNR2SMN1; SMN2MAPT | |
| SCHEMBL18002204 | 0.84 | ERN1 (0.53) | ERN1KCNH2CNR1CNR2SMN1; SMN2 | |
| SCHEMBL154628 | 0.83 | LTA4H (0.53) | ERN1KCNH2SMN1; SMN2MAPTPDK2 | |
| SCHEMBL8002483 | 0.82 | KIF11 (0.56) | ERN1KCNH2PDK2CYP2E1CYP3A4 | |
| SCHEMBL20595524 | 0.80 | KCNH2 (0.48) | ERN1KCNH2MAPTKDM4ECYP2E1 | |
| SCHEMBL4338418 | 0.78 | KCNH2 (0.58) | ERN1KCNH2MAPTKDM4ECYP2E1 | |
| SCHEMBL1334921 | 0.73 | KCNH2 (0.59) | ERN1KCNH2MAPTKDM4ECYP2E1 | |
| SCHEMBL15203026 | 0.73 | KCNH2 (0.50) | ERN1KCNH2SMN1; SMN2MAPTPDK2 | |
| SCHEMBL788391 | 0.72 | MAPT (0.54) | ERN1KCNH2SMN1; SMN2MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3048107-B1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | FUTURE INK CORP (JP) | 2021-01-13 | — | — | EP | disclosed |
| US-9978954-B2 | Benzobis (thiadiazole) derivative, ink comprising same, and organic electronic device comprising same | UBE INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160276598-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK COMPRISING SAME, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | FUTURE INK CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
| EP-3048107-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | UBE Industries, Ltd. (JP) | 2016-07-27 | — | — | EP | disclosed |
| WO-2015041026-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | 宇部興産株式会社 | 2015-03-26 | — | — | WO | disclosed |
| EP-2454261-B1 | IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | UNIV SIENA (IT) | 2014-11-19 | — | — | EP | disclosed |
| US-8546147-B2 | Imidazo[1,2-α]pyrazin-3(7H)-one derivatives bearing a new electron-rich structure | UNIVERSITA DEGLI STUDI DI SIENA (IT) | 2013-10-01 | — | — | US | disclosed |
| US-20120171703-A1 | IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | UNIVERSITÁ DEGLI STUDI DI SIENA (IT) | 2012-07-05 | — | — | US | disclosed |
| EP-2454261-A1 | IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | Universita Degli Studi di Siena (IT) | 2012-05-23 | — | — | EP | disclosed |
| WO-2011007314-A1 | IMIDAZO[1,2-α]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | UNIVERSITÀ DEGLI STUDI DI SIENA (IT) | 2011-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276598-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK COMPRISING SAME, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | BRD3, TH, BRS3 | ERN1 626/4885KCNH2 872/4885CNR1 3035/4885 |
| US-20120171703-A1 | IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | GLB1, NDUFV1, IK | ERN1 1744/4885KCNH2 735/4885CNR1 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.